Mark Alan Goldberg - 29 Mar 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Issuer symbol
GLYC
Transactions as of
29 Mar 2024
Transactions value $
$13,752
Form type
4
Filing time
02 Apr 2024, 16:05:22 UTC
Previous filing
12 Feb 2024
Next filing
01 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Award $13,752 +4,584 +22.64% $3 24,828 29 Mar 2024 Direct F1
holding GLYC Common Stock 11,497 29 Mar 2024 By family trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $13,750.